Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2004, p. 3909-3910, Vol. 42, No. 8
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.8.3909-3910.2004
| LETTER TO THE EDITOR |
|
|
|---|
As of 1997 it was officially accepted by the World Health Organization (WHO) (7) that E. histolytica sensu lato is composed of two morphologically identical species: the pathogenic E. histolytica and the nonpathogenic, but very common, Entamoeba dispar. These two parasites cannot be correctly distinguished by microscopy alone unless the trophozoites in question are seen engulfing red blood cells. In that case microscopy could be diagnostic, but even the correct diagnosis appears difficult (2).
Finding of entamoeba trophozoites or cysts in bloody diarrhea is not enough to draw conclusions on causality. Our extensive experience with the diagnosis and epidemiology of amebiasis in Ethiopia revealed that, in contrast with the general belief, E. histolytica is quite rare (2-4). Not only in asymptomatic cases, but even in patients with bloody diarrhea, the great majority of trophozoites and cysts found appeared to belong to either E. dispar or altogether different intestinal amoeba (2). Similar results were reported from Cote d'Ivoire (1) and Ghana (6). Unless powerful species-specific diagnostic tests are used, we have to believe that most of these reported cases of "E. histolytica" are in fact cases of E. dispar or altogether different amoeba. We would like to point out that it is incorrect to report E. histolytica using conventional microscopy alone to come to such a sweeping conclusion. Important conclusions, both at the individual level and at the population level, require inclusion of species-specific tests like PCR.
|
|
|---|
|
Amha Kebede*
Ethiopian Health & Nutrition Research Institute/Ethio-Netherlands AIDS Research Project, P.O. Box 1242 Addis Ababa, Ethiopia
Anton M. Polderman
|
||||||
|
* Phone: 251-1-751522 E-mail: amha{at}enarp.com |
|
|
|---|
We are in agreement with Kebede and Polderman on the methodological limitations of that part of our study, but we find insufficient basis to speculate that most of the amoeba reported were nonpathogenic. The epidemiology of E. histolytica and other intestinal pathogens is known to vary geographically (1, 3, 4), and the conclusions drawn from comparisons with data from considerably dissimilar studies are not in any way supported by our findings. Recovery of Entamoeba was very strongly associated with diarrhea in our study (P < 0.0002), and the E. histolytica complex was the most common agent detected in bloody diarrhea specimens in which only one agent was found. Therefore, our data do suggest an association of the E. histolytica complex with diarrheal disease, even if the specific contribution of E. histolytica sensu stricto cannot be assessed. The claim that E. histolytica is unusual in acute infection is not supported by our data or by other published literature, including recent studies employing discriminatory tests. For example, Haque et al. recently demonstrated that E. histolytica is an important cause of acute and bloody childhood diarrhea (1). Thus, we feel that these should be areas of future investigation, rather than speculation, and prefer to restate that there was an association of the E. histolytica complex (E. histolytica and E. dispar) with disease.
WHO issued a statement a few months before our study was conducted on the potential significance of nondelineation of E. histolytica from E. dispar and recommended the development of suitable methodology (6). Notably, the most recent version of the WHO Manual of Basic Techniques for a Health Laboratory, published 6 years later (7), describes only wet-mount microscopy even though it mentions the problems with specificity. This practical consideration arises from the undeniable fact that stool microscopy continues to be the only technology available to many laboratories in areas of endemicity (5). Immunological tests offer greater portability but are often too expensive to be employed routinely in developing countries. They also require cold-chain transportation that may be unavailable and, in the case of antibody tests, fail to distinguish between current and past infections (4, 5). Molecular epidemiology studies conducted in Africa, including our study and the work cited by Kebede and Polderman, have invariably involved partnerships with industrialized countries. This approach, while useful for small research studies, is inadequate and unsustainable for much-needed larger studies or for clinical diagnostics. Thus, as in our paper, Kebede and Polderman emphasize the necessity for capacity building for molecular diagnostics in sub-Saharan Africa. Definitive identification of important diarrheal pathogensE. histolytica as well as diarrheagenic E. coli, the central focus of our studycannot be conducted without it.
|
|
|---|
|
Iruka N. Okeke*
Department of Biology Haverford College 370 Lancaster Ave. Haverford, PA 19041
Oladipupo Ojo
Adebayo Lamikanra
James B. Kaper
|
||||||
|
* Phone: (610) 896-1470 Fax: (610) 896-4963 E-mail: iokeke{at}haverford.edu |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»